More than half of the population with HIV in the world live in sub-Saharan Africa. HIV-
associated chronic lung disease is the most prevalent comorbidity among children and …

BACKGROUND: HIV infection causes impairment of the gastrointestinal barrier, with
substantial depletion of CD4+ T-cells in the gut. Antiretroviral therapy (ART) restores CD4+ …

Sub-Saharan Africa remains the region with the highest burden of HIV among both children
and adults. Access to antiretroviral therapy (ART) has improved survival, yet data on long …

Background Human immunodeficiency virus (HIV) infection causes impairment of the
gastrointestinal barrier, with substantial depletion of CD4+ T cells in the gut. Antiretroviral …

Chronic lung disease (CLD) is a common co-morbidity for HIV-positive children and
adolescents on antiretroviral therapy (ART) in sub-Saharan Africa. In this population, distinct …

Multiple factors, such as immune disruption, prophylactic co-trimoxazole, and antiretroviral
therapy, may influence the structure and function of the gut microbiome of children infected …

Background: HIV-associated chronic lung disease (HCLD), predominantly obliterative
bronchiolitis, affects more than 30% of perinatally HIV-infected children in Sub-Saharan …

Therapeutic interventions aimed at modulating the gut microbiome in children with HIV have
shown limited impact, and their ability to induce long-term microbiome changes remains …

Objective We investigated the impact of human immunodeficiency virus (HIV) infection and
anti-retroviral therapy (ART) on the gut microbiota of children. Design This cross-sectional …

HIV-associated chronic lung disease (HCLD) is responsible for over half of all HIV-related
deaths in children. Long-term treatment with the antibiotic azithromycin can reduce the …